Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with
arterial and venous thrombotic complications. In a US registry of patients with coronavirus …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
(SARS-CoV-2) is associated with a heightened risk of thrombotic events. 1 We sought to …

May 4, 2020, there are> 1.2 million confirmed cases in the United States and> 66 000
deaths. Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) was identified as a new
coronavirus causing pneumonia and acute respiratory distress syndrome. It has become a …

We were very interested to read the article published by Klok et al. reporting the incidence of
thrombotic complications in critically ill ICU patients diagnosed with Covid-19 [1]. The article …

Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Background Coronavirus disease 2019 (COVID-19) predisposes to arterial and venous
thromboembolic complications. We describe the clinical presentation, management, and …

The pathogenic coronavirus has been wreaking havoc worldwide since January. Infection
with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral …

Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …

Objective Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus confers a risk of significant coagulopathy, with the resulting development of venous …